Source: valneva.com

Valneva received $41.3M in Grant Funding

Followers on Owler

Annual Revenue

$100-500M

Employees

500-1.0K

President & CEO

Thomas Lingelbach

CEO Approval Rating

90/100

Valneva is a France-based biotechnology company that develops and commercializes vaccines for the treatment of infectious diseases.